iBio Inc. (AMEX:IBIO) saw a downside of -7.19% to close Friday at $0.40 after subtracting -$0.03 on the day. The 5-day average trading volume is 661,280 shares of the company’s common stock. It has gained $0.4750 in the past week and touched a new high 1 time within the past 5 days. An average of 791,280 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 734,692.
IBIO’s 1-month performance is -28.32% or -$0.1700 on its low of $0.3922 reached on 08/18/23. The company’s shares have touched a 52-week low of $0.36 and high of $16.51, with the stock’s rally to the 52-week high happening on 03/21/23. YTD, IBIO has lost -9.99% or -$0.0444 and has reached a new high 12 times. However, the current price is down -97.58% from the 52-week high price.
Insider Transactions
IBIO stock investors last saw insider trading activity on Jul 27.Brenner Martin () most recently sold 4,515 shares at $0.51 per share on Jul 27. This transaction cost the insider $2,308., Brenner Martin, sold 47,020 shares at a price of $0.59 on Jul 12. Then, on Jun 21, Brenner Martin sold 4,184 shares at a price of $0.68 per share. This transaction amounted to $2,849.
Valuation Metrics
IBIO stock has a beta of -3.12. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 19.44 while the price-to-book (PB) in the most recent quarter is 0.30.
The trailing 12-month EBITDA margin is -1951.24%. The firm’s gross profit as reported stood at $2.17 million against revenue of $2.38 million.
Earnings Surprise
Net income shrunk -63.79% to -$7.29 million, while revenue of -$33.55 million was -360.22% off the previous quarter. EBITDA for the quarter stood at more than -$5.84 million. IBIO stock balance sheet for the recent quarter shows that total liabilities totaled 27.0 million, with total debt at $18.43 million. Shareholders hold equity totaling $16.8 million.
Let’s look briefly at iBio Inc. (IBIO) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 18 August was 33.08% to suggest the stock is trending Neutral, with historical volatility in this time period at 64.80%.
The stock’s 5-day moving average is $0.4222, reflecting a -9.93% or -$0.0441 change from its current price. IBIO is currently trading -27.27% above its 20-day SMA, -83.54% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -48.59% and SMA200 by-81.74%.
Stochastic %K and %D was 4.04% and 4.49% and the average true range (ATR) pointed at 0.0544. The RSI (14) points at 34.37%, while the 14-day stochastic is at 1.92% with the period’s ATR at 0.0539. The stock’s 9-day MACD Oscillator is pointing at -0.0312 and -0.0686 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for iBio Inc. (AMEX: IBIO), JMP Securities launched coverage with a Mkt outperform rating. Analysts offering their rating for IBIO stock have a consensus rating for the stock as Hold. Currently, 0 brokerage advisors rate IBIO as a “sell,”, while 1 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 0 have offered a “buy” rating.
What is IBIO’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $1.00 and a high of $1.00, with their median price target at $1.00. Looking at these predictions, the average price target given by analysts is for iBio Inc. (IBIO) stock is $1.00.
